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Background: Nidrakar Bati (NKB) is an herbal remedy consisted with seven medicinal herbs widely used to cure
Somnifacient (sleeping aid) in South Asia as Ayurvedic medicinal system. In the present study, pharmacological and
toxicological effects of this medicine was investigated in mice to validate the safety and efficacy of the herb.
Methods: Organic solvent extracts NKB were prepared using maceration method. Effect of extracts on the central
nervous system was evaluated using hypnotic activity assay. Effect of the extracts on metabolic activity, assessing
involvement of thyroid was conducted using hypoxia test. analgesic and anti-inflammatory activities were assessed
in mice using acetic acid induced writhing, formalin induced paw edema, xylene induced ear edema assays.
Anxiolytic activity was performed using plus maze, climbing out and forced swimming tests. Effect of the extracts
on psychopharmacological effect was carried out using locomotor activity tests (open field, Hole-board and
Hole-cross tests). Neuropharmacological effect of the extracts was performed using motor coordination (rotarod
test). Toxicological potential of the extract was evaluated using gastro-intestinal activity (gastric emptying and
gastrointestinal motility tests).
Results: The studied formulation reduced the CNS stimulant effects dose independently. In the hypoxia test, only a
dose of 100 mg/kg of NKB decreased the survival time. Orally administration of the NKB (200 and 400 mg/kg)
produced significant inhibition (P < 0.01) of the acetic acid-induced writhing in mice and suppressed xylene induced
ear edema and formalin-induced licking response of animals in both phases of the test. NKB showed locomotor
activity (p < 0.05) both in higher and lower doses (100 and 400 mg/kg). NKB increased the total ambulation dose
dependently (p < 0.05). NKB, at all tested doses (100, 200 and 400 mg/kg) increased some locomotion activity
parameters (ambulation, head dipping and emotional defecation) in hole board test. At higher doses (200 and
400 mg/kg), NKB showed a significant increase in hole cross test. NKB showed an increase in the time on the open
arms of the maze at low to medium doses (100 and 200 mg/kg). When using the Rotarod method, NKB showed a
considerable increase on motor coordination of the mice. NKB produced marked gastric emptying effect and
decreased gastrointestinal motility in mice at low dose.
Conclusions: NKB demonstrated various pharmacological effects and toxicological effects due to presence of
several herbs in the formulation those are not closely fit for the effect of CNS depressants.
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Herbs are useful for the treatment of different diseases
that affect human and animal. They are good starting
points for the discovery of bioactive molecules for drug
development. Ethnomedicinally, herbs are used for pain
relief, wound healing and abolishing fever that bring use-
ful information to identify a wide range of compounds
to develop new therapies for cancer, hypertension, dia-
betes and anti-infective medicines [1]. Herbs contains
not only useful medicinal constituents but may also
harmful substances [2]. Over 1500 herbal products sold
are nutraceuticals which are exempt from extensive pre-
clinical efficacy and toxicity testing by the US FDA in
2003 [3].
Nidrakar Bati (NKB) is widely prescribed for a variety
of conditions, particularly insomnia. In South Asia re-
gion, people of Bangladesh, India, Pakistan, Srilanka,
Nepal and Bhutan use NKB for insanity, insomnia,
swooning, and headache. It is relatively safe and with
overdose may result in death and addicting and abuse by
patients with addiction disorders. NKB is normally used
for the CNS diseases (Insomnia). This drug has some
other effects on CNS and peripheral nervous system.
This herbal medicine has shown some other pharmaco-
logical and toxicological effects as reported by patients.
This make concerns about potential harmful as well as
useful effects of this herbal medicine to justify the acute
high-dose effects, chronic low-dose toxicity and specificTable 1 Medicinal plants cross checked by “The Plant List” (w



















































Araceae 7.14% Rhizcellular, organ and system-based toxicity assays. Despite
the growing market demand for this herbal medicine,
there are still concerns associated with not only its use,
but its safety. Caution must be used when prescribing
NKB to patients. This raises alarming condition on its
safety and implications for its use as medicine. Toxicity
testing makes know the risks that may be associated
with use of multiple herbs to avoid potential harmful ef-
fects when used as medicine.
NKB is produced using many medicinal plants in many
doses. The formulation of NKB is varied from region to
region. Seven medicinal plants of Nardostachys jatamamsi
DC., Rauvolfia serpentina (L.) Benth. ex Kurz., Canscora
decussata (Roxb.) Schult., Phyllanthus Emblica Linn.,
Datura Stramonium Linn., Cannabis Sativa Linn., Acorus
Calamus Linn. (Table 1) were used to formulate this
herbal medicine. Nardostachys jatamamsi DC. is an erect
perennial herb grows up to 60 cm in height and used as
folk medicine for pitta, vata, burning sensation, insanity,
epilepsy, asthma, bronchitis, headache, inflammations,
colic, flatulence, hepatitis, kidney diseases, low back pain,
hypertension, graying or falling of hair and general debil-
ity. Rauvolfia serpentina (L.) Benth. ex Kurz. is a small
erect shrub grows up to 60 cm in height. It is used as folk
medicine for vitiated kapha, vata, hypertension, insanity,
epilepsy, insomnia, wounds, fever, colic and urinary reten-
tion. Canscora decussata (Roxb.) Schult. is a small erect
annual herb grows up to 50 cm in height and used as folkww.theplantlist.org) used in the formulation of Nidrakar
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bility, pain, skin diseases, ulcer, worms, abdominal disor-
ders and general debility. Phyllanthus emblica Linn. is a
medium sized deciduous tree grows up to 25 meters in
height. It is used as folk medicine for tridoshas, constipa-
tion, stomatitis, jaundice, disorders of vision, fever, cough,
wheezing, cardiac disorders and general weakness. Datura
Stramonium Linn. is an erect spreading annual or biennial
plant grows up to 2 meters in height and used as folk
medicine for vata, kapha, arthritis, cough, asthma, muscle
spasm, fever, ulcer, skin diseases, lumbago, sciatica and
dandruff. Cannabis Sativa Linn. is an erect annual herb,
grows up to 5 m in height and used as folk medicine for
vitiated vata, pain, Insomnia, abdominal disorders, cough,
insanity, erectile dysfunction, and inflammation. Acorus
Calamus Linn. is a rhizomatous, perennial semi aquatic
plant grows up to 40 cm in height and it is useful for the
treatment of vata, kapha, insomnia, insanity, mental dis-
eases, epilepsy, mania, stomatitis, hoarseness of voice,
colic, flatulence, amenorrhea, dysmenorrhea, neuropathy,
renal calculi, cough, inflammation, arthritis, kidney dis-
eases, hemorrhoids, skin diseases and general debility.
The molecular mechanism of action of NKB is still un-
known. About 10% of herbal product in the world is
truly standardized to known active components. Strict
quality control measures are not always diligently ad-
hered to safety [4]. Very little is known about the active
and toxic constituents of majority of the herbal prod-
ucts. Herbal medicines are not subjected to the same
regulatory standards as orthodox drugs in terms of efficacy
and safety in developed countries of USA, UK, Europe and
Canada. There is an increasing concern to use safe herbal
medicine. Many herbs are responsible of adverse reaction
during receiving allopathic drugs. Most of the effects were
found in pregnant women and children. The increasing
knowledge on herbs provides a scientific definition to de-
sign a rational herbal medicine and filter the compounds
that produce toxicities. Generally, patients do not share the
information of their herbal medicine with the physician.
This behaviour leads lack of surveillance to monitor the
herbal medicines and proper guideline for combined use of
modern drugs and herbal medicine. As a result, the herbal
medicine may show complementary activity or adverse
herb-drug interactions. Therefore, the present study was
performed to screen the pharmacological effects, toxico-
logical effects and optimization of these effects for NKB by
using in vivo study.
Methods
Drugs and chemicals
The NKB was collected from Sree Kundeswari Aushadhalya
Ltd., Chittagong 4342, Bangladesh. The powdered tab-
lets were dissolved to make solution to measure opti-
mal dosage. The drug was administered orally at a doseof 100 mg/kg body weight. Barium sulphate (BaSO4),
Carboxy methyl cellulose (CMC) was purchased from
Merck, Germany. Pentobarbital were bought from Sigma
Company (St Louis, MO, USA). Pentobarbital were dis-
solved in saline: tween 80 (9:1). All the solutions were
freshly made on the day of testing and administered to a
final volume of 10 mL/kg body weight of mice.
Animals
Male (six weeks old) Swiss-Webster strain mice (20–40
gm body weight) were purchased from Animal House
Department, ICDDR’B, Bangladesh. Animals were main-
tained under constant temperature (24 ± 2°C), 12 h
light–dark cycle, relative humidity 40–70%, fed with
food (mouse chow, BCSIR, Bangladesh) and water ad
libitum and fasted overnight (18 h) before the day of the
experiment. All screening procedures carried out ac-
cording to the guidelines of international guideline out-
lined in the guide for the care and use of laboratory
animals (National Research Council) [5]. The animal
handling protocol of the present study was submitted to
the institutional animal ethics committee, “Experimental
Animal Ethics Committee, UODA” for evaluation and
Animal experiment protocol was approved by the com-
mittee (approval Reference number: e/m-7PHA040294).
Industrial manufacturing process of NKB
The batch number of collected NKB was 02-P-04\09\09-
E10\11, DAR no. 58A-152 and each tablet (500 mg) con-
tained 100 mg Nardostachys jatamamsi DC., 50 mg
Rauvolfia serpentina (L.) Benth. ex Kurz., 50 mg Canscora
decussata (Roxb.) Schult., 20 mg Phyllanthus emblica Linn.,
20 mg Datura stramonium Linn.,20 mg Cannabis sativa
Linn., and 20 mg Acorus calamus Linn. The whole/partial
part of these plants are dried and attach it with 44 X 32
inch art paper and submitted to identification purpose in
the Herbarium and specimen voucher no. is mentioned in
the Table 1.
The manufacturing process of tablet is depicted following:
Method of extraction
Most of the plants used for NKB production purposes
are cultivated, that is, grown on farms. Some, however,
may be collected from the wild. After harvesting and
collecting, the plants were cleaned. Unnecessary parts
were removed before. Plants were shed dried first. Then
put in the large room with proper air permeability for
several weeks at room temperature and 65% relative hu-
midity. Fresh plants placed on a conveyor belt to pass
under the warm air for 2.5 to 6 hours, and the temperature
of the drying air ranges from 40 to 80°C. After drying,
plants were packaged for next processing. Dried herbaceous
plants were generally compressed into bales weighing from
60 to 100 kg (13 to 220 pounds), which were kept in plastic
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such as roots and bark, were placed in sacks. Dried plant
materials were stored under controlled humidity and
temperature in sealed container. The sacks were passed
into processing facility to remove impurities.
Sand and iron-containing metals were removed pneu-
matically and magnetically, respectively. Next, machine
sorts out plant parts according to size. Shredded materials
were used for extraction. Large size particles were treated
with additional crushing and sieving. Organic solvent ex-
traction was used to separate the plant constituents. The
plants were first ground and then thoroughly mixed with
a solvent methanol in the large aluminium container. Dis-
solved active ingredient of the plant was used. Standard
filtration was applied exchange to separate impurities
from the plant extract. Rota evaporator was used to
thicken the extract. Extracts were completely dried using
cabinet vacuum dryers with the goodness of moisture and
stability. Then obtained powdered extract was preserved
since it has no ability to contaminate with microbes.
Preparation of the final formulation
NKB Tablets were made using magnesium stearate and
gums. The quantity of excipients were less than 50% of
the weight of the finished product.
Quality control of extracts
Several methods were performed to determine the quality
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The specification mentioned in the table obtained from quality control lab of Sree K
compared to this specification.solubility, total solids content, ash content, and particle size
were determined using standard testing procedure men-
tioned in the Table 2. Thin Layer Chromatography (TLC)
was used to identify the phytoconstituents from the extract.
Microbial contamination was tested by the disc diffusion
method. The extract concentration in the tablet was deter-
mined by standard mathematical analysis, i.e. tablet con-
taining 500 mg of extract standardized to 50 percent that
will be 250 mg of extract.
Thin layer chromatography (TLC) of methanolic Extract and
NKB tablet
Standard size TLC plates were cut into small pieces as
Length – 7 cm, Width – 2.5 cm, Labeling space – 1 cm
from both upper & lower side. Both the plant extract
and NKB tablet were used for chromatographic separ-
ation by TLC method. TLC plates in Iodine chamber
showed a significant results in 9:1, 8:2, 7:3 and 6:4 mo-
bile phase solvent ratio (n-hexane : ethyl acetate) and
found spots in TLC with Rf values 0.65, 0.69, 0.68, 0.67
and indicated different verities of compounds.
Treatment
Mice were divided into 10 groups. Each group had ten
mice. All experimental extract and standard medicine
were administered orally. Mice were received 10 mL/kg
normal saline as vehicle and served as a negative control
for the NKB. NKB administered mice groups received
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and 13:00 every day to avoid any temporal factor. Each ani-
mal was used for only one experimental condition.
Hypnotic activity (CNS effects)
Pentobarbital sleeping time test NKB was adminis-
tered orally (100, 200, 400 mg/kg) 60 min afterwards
mice were administered with sodium pentobarbital
(45 mg/kg, oral). The time from the loss of rightness re-
flex to awakening (duration of sleeping) were calculated
(in minutes) for each animal [6]. Mice were given a sin-
gle oral dose of the vehicle, diazepam (2 mg/kg) as the
reference drug. These treatments were carried out
60 min before challenging the animal with oral dose of
pentobarbital (45 mg/kg). To investigate the possible
mechanism involved in the hypnotic activity of NKB, the
animals were pretreated with flumazenil (10 mg/kg), an-
tagonist of GABAA–benzodiazepine receptor.
Metabolic activity
Hypoxia test Mice were placed in an air tight empty
glass jar of 300 mL capacity attached with an electronic
watch, and the onset of convulsion time was recorded
[7]. The hypoxia time was recorded after 2 hr.
Analgesic and Anti-inflammatory activity
Acetic acid induced writhing The NKB was evaluated
for analgesic activity in mice using acetic acid induced
writhing [8] tests described below. Mice were injected
intraperitoneally with 0.6% aqueous acetic acid (10 ml/
kg) 30 min after oral administration of NKB (100, 200,
400 mg/kg) or vehicle (Saline, 10 ml/kg). The reference
group was given Diclofenac sodium (25, 50, 100 mg/kg).
The number of writhing movement (painful Muscular
contraction) of each mouse was counted for 10 min,
starting from 15 min after the injection of acetic acid.
The average number of writhes and the percent protec-
tion were calculated as following:




Where N is the average number of stretch of control
animals per group And Nt is the average number of
stretching of treated animals per group.
Formalin induced paw licking test The applied method
was similar to previously described process of Correa
and Calixto [6]. Eighty microgram of 1% formalin solu-
tion (Sigma) was administered subcutaneously in the
right hind paw for the induction of pain. The duration
of time in licking the injected paw was monitored. After
5 min of formalin injection, the first nociceptive re-
sponse (first phase: neurogenic) was counted. Aftertwenty min of formalin injection, the second phase (in-
flammatory) was recorded. The mice were pretreated
with NKB at 1 h, before formalin injection, and the re-
sponses were observed for 30 min.
Xylene-induced ear oedema test Xylene (0.03 ml) was
injected in the right ear (anterior and posterior surface)
after 30 min of the injection (i.p.) of NKB. Dexametha-
sone (50, 150 and 300 mg/kg, b.w.) was used as positive
control. The untreated mice group was considered as
control. Mice were killed after 2 h xylene injection. The
ears were removed from NKB treated, positive control
and control groups of mice. The subtracted weights
from the experimented groups were calculated [9,10]
using following formula:
Oedema reduction inhibition% ¼ Rt−Lt
Rc−Lc
 100
Where Rt =mean weight of the right ear plug of the
treated animals; Lt = mean weight of the left ear plug of
the treated animals; Rc =mean weight of the right ear
plug of the control animals; Lc =mean weight of the left
earplug of the control animals.
Psychopharmacological activity
Open field test A white colored open floor of 100 ×
100 cm divided by red lines into 25 squares of 20 ×
20 cm [11]. The place was fenced (50 cm) with white
color. The test was conducted at the normal day light
maintaining same intensity of light. Each mouse was
kept in the center of the open field, and its behavior was
observed for 5 min. Some locomotion parameters total,
peripheral and central locomotion were determined ac-
cording to the total number of squares crossed, the
number of outer squares adjacent to the walls crossed,
How many leanings (one to two paws touching the wall),
parenting, grooming (face cleaning, paw licking, fur lick-
ing, scraping and also rubbing), respectively [12]. Loco-
motion or Ambulation was determined as the number of
times crossing the square with all four limbs, if periph-
eral squares it is peripheral ambulation, if it is central
squares then it is central ambulation. Also other noted
parameters were standing up behavior (Immobilization)
time and Emotional defecation (Urination).
Hole board test The three doses of NKB (100, 200 and
400 mg/kg) was administered orally 60 min before test
and standard group was treated with diazepam (2 mg/
kg) intraperitoneally 30 min before test. The control
group was treated with normal saline, before the test of
60 min. Initially mouse was kept in the edge of the board
(constructed with 16 × 3 cm in diameter). the number of
ambulation (the number of holes passed), head dipping
and number of fecal boluses excretion were taken as the
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and 240 minutes [13].
Hole cross test A box (30 × 20 × 14 cm dimension) with
a hole of 3 cm in diameter and 4.5 cm in height from the
floor was constructed. Spontaneous movement of the ani-
mals through the hole from one to the other was counted
[14,15]. The observation was conducted 30, 60, 120, 180
and 240 minutes after oral administration of test drugs.
Anxiolytic activity
Climbing out test Mice were kept in the cage (60 × 50 ×
30 cm) surrounded by black colored. Mice were trained
prior the test to climb a ladder of (6 cm long) suspended
from a clamp of a retort stand (100 cm above ground). A
ladder was provided and time was taken to climb of the
cage. Only mice those climbed the ladder within 10s were
selected for the test. This test was carried out 30 min after
treatment with NKB and diazepam and normal saline were
used as control (sec).
Elevated plus maze test The three doses of NKB (100,
200 and 400 mg/kg) were administered orally 60 min be-
fore test and the standard group was treated with diaze-
pam (2 mg/kg) intraperitoneally 30 min before test. The
control group was treated with normal saline orally,
60 min before test. At the beginning of test, mice placed
on the open arm facing the center of the plus maze. The
time (s) spent by mice in the open and closed arms was
recorded. Anxiolytic compounds reduced the mice’s nat-
ural aversion to the open arms and support exploration.
Therefore, increased time spent in the open arms was
defined to reflect an anxiolytic effect, in comparison
with the control group [16].
Forced induced swimming test Forced swimming test
(FST) is usually used as Pharmacological model for anti-
depressant action. The mice were treated with the NKB
(100, 200 and 400 mg/kg, oral), Diazepam (2 mg/kg, IP)
and saline solution before 45 min of the test. The forced
swimming mice exposed to passive and immobile after a
period of vigorous activity (struggling) to keep their
heads above the water. Swimming sessions were con-
ducted in individual Plexiglass cylinders (40 × 20 cm)
containing 20 cm of water at 24 ± 1°C. Mice were forced
to swim for 6 min and the time spent in immobility dur-
ing the last 5 min of 6 min observation period was re-
corded manually by the competent observer [17].
Neuropharmacological activity
Rotarod test Pharmacological effects of anxiolytic drugs
are tested to analysis the loss of coordinated motor
movement [18]. Coordinated motor activity of NKB was
assessed using rotarod test [18]. Previously trained miceadapted to rotarod apparatus (3 cm in diameter, 8 rpm)
for 120 seconds and at least two times for each animal.
After twenty four hours mice were injected with vehicle
(saline), NKB (100, 200 and 400 mg/kg) orally and
placed in instrument 1 hour later. Immediately (in sec-
onds) dropped off mice from the rotarod was recorded
up to a limit of 100 seconds [19].
Toxicological activity
Gastric emptying time Sixteen male Swiss-Webster
mice were fasted for 18 hours prior to experiments. The
described method of Droppleman et al. [20] and Martinez
et al. [21] was used here. Rats fasted for 24 h prior to the
experiment received distilled water (10 ml/kg) and NKB
(100, 200 and 400 mg/kg). One hour after, 3 ml of a semi
solid test meal (based on methyl cellulose) was adminis-
tered to the mice. The mice were sacrificed and laparato-
mized 1 h after the treatment and the stomach removed.
The full stomach was weighed, opened and rinsed, excess
moisture was mopped and the empty stomach weighed.
The difference was subtracted from the weight of 3 ml of
the test meal, and was taken as the quantity emptied from
the stomach during the test period.
% GE ¼ Gastric Contents
Total Food Intake
 100
Gastrointestinal motility test GI motility test was car-
ried out to find the effect of the drugs on the peristaltic
movement of the GI tract [22]. The mice (25 to 35 g)
were fasted 18 to 24 hr before beginning of the experi-
ment. Control group was given normal saline (10 ml/kg)
orally, and Positive Group treated with antimotility drug
Loperamide (3 mg/kg, p.o.) was used as the standard
drug. Remaining groups were treated with NKB (100,
200 and 400 mg/kg, oral). BaSO4 milk was prepared by
adding BaSO4 at 15% w/v in 0.5% CMC suspension. After
30 min of administered saline, castor oil and NKB, the
BaSO4 milk was administered (5 mg/kg oral). After
15 min of administering BaSO4 milk, the animal was
killed by cervical dislocation and dissected out. The
dissected animals were placed on clean surface and the
distance travelled (from pylorus to the ileoceccal junction)
by BaSO4 milk was measured. Then GIT motility was
calculated for all groups. The percent motility was calcu-
lated using the following formula:
Percent Motility
¼ 100– Distance covered=total length of intestineð Þ
 100:
Statistical analysis
Data are expressed as mean ± SD (Standard Deviation).
The statistical significance was determined using the
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nificance as compared to the control group.
Results
Physicochemical parameters of tablet and extract were
tested using standard lab analysis protocols and obtained
results were satisfactory but limited according to specifi-
cations (Table 2).
Analgesic and anti-inflammatory activity
Acetic acid induced writhing
The different doses of the NKB (200 and 400 mg/kg)
decreased writhing response induced by acetic acid ad-
ministered intraperitoneally to mice (Figure 1) in a
dose-dependent manner. The standard analgesic diclo-
fenac sodium (25 mg/kg, b.w.) reduced the abdominal
constriction to 90%.
Xylene-induced ear oedema test
There were significant differences between the NKB and
control groups after treatment (Figure 1).Figure 1 Analgesic and anti-inflammatory activity of NKB with various doses
100 mg/kg/day) and dexamethasone were performed in mice model. Dose d
diclofenac and dexamethasone. Diclofenac with 25 mg/kg/day and dexameth
was compared based on this activity. Three mice models were used for in viv
such as (A) acetic acid induced writhing response (p < 0.01), (B) xylene induc
(D) formalin induced – inflammation (p < 0.05). Analgesic effects come from t
ethanol extract of Nardostachys jatamansi DC. Also, flavonoids from Rauvolfia
hydro-methanolic extract, water fraction of fruits butanol extract of Phyllanthu
of cannabigerol, cannabichromene, cannabidiol, delta-9 tetrahydrocannabinol, de
essential oil and alcoholic extract of the rhizomes of Acorus calamus Lin
decussata (Roxb.) Schult. has no analgesic activity till now and hence it
stramonium Linn. has anti-inflammatory activity, it is not recommended
hypoactivity, and liver weight loss. Phyllanthus emblica L. has strong cytotox
hence minimum quantity is recommended in NKB formulation.Formalin induced paw licking test
The nociceptive responses were quantified by the time
of paw licking after the formalin injection. The results
depicted in Figure 1 showed that the NKB caused sig-
nificant inhibition of both neurogenic and inflammatory
phases of formalin-induced licking. Its antinociceptive
effects were significantly more pronounced than diclofe-
nac (25 mg/kg). The second phase was more reduced
than first phase at the dose of 400 mg/kg of NKB.
Psychopharmacological activity
Open field test
About all doses of NKB and diazepam (3 mg/ kg) low-
ered the open field characteristics except total ambula-
tion (Figure 2).
Hole board test
In the hole-board test, a significant reduction in the
number of head dips at the doses of 100 mg/kg by oral
route administration with the exception at the dose of
200, and 400 mg/kg, the NKB did not reduce the num-
ber of head dips (Figure 3).(100, 200, 400 mg/kg/day) and standard drugs diclofenac (25, 50,
ependent activity of NKB was observed that was reproduced with
asone with 50 mg/kg/day showed highest efficacy and the result of NKB
o experiments to determine the analgesic and anti-inflammatory activity
ed ear oedema (p < 0.01), (C) formalin induced –analgesic (p < 0.05),
he active principle of jatamansone (structure shown) and 50% rhizomes
serpentina (L.), ascorbic acid, tannins and polyphenolic compounds,
s emblica L., ethanolic extracts of Datura stramonium Linn., active principles
lta 9 tetrahydrocannabivarin of Cannabis sativa Linn., phenolic compounds,
n. are responsible for the anti-inflammatory activity. Since Canscora
is not suggested to use in NKB formulation. Although Datura
due to alkaloids atropine and scopolamine for diarrhea, vomiting,
ic activity (Table 3) due to phytosterol and phenolic compounds and
Figure 2 Psychopharmacological activity was determined by open field test using (A) total ambulation (B) central ambulation (C) standing up
behaviour (D) emotional defecation parameters in mice. (p < 0.05). The active principles of serpentine (structure shown, B) of Rauvolfia serpentina
(L.), total xanthones (structure shown, C) of Canscora decussata (Roxb.) Schult., cannabidiol (structure shown, D) of Cannabis sativa Linn. may be
the reason for such effect.
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In the hole cross test only one group of mice showed better
locomotor activity after the treatment of NKB and other
groups did not response properly (Figure 3). As results
400 mg/kg of NKB decreased the locomotion that was
more reduced after the treatment of Diazepam (2 mg/kg).Figure 3 Anxiolytic activity was found in hole board test by observing am
(C) parameters and in hole cross test by locomotor (D) (p < 0.05) parameters
of Canscora decussata (Roxb.) Schult., mangiferin (structure shown) of CanscoAnxiolytic activity
Climbing out test
In climbing test, loss of coordination was found signifi-
cantly in mice with orally treated of NKB dose depend-
ently (Figure 4). The results were better than Diazepam
(2 mg/kg) treatment.bulation (A) (p <0.05), head dipping (B), emotional defecation
in mice. This activity of NKB may be due to presence of total xanthones
ra decussata (Roxb.) Schult., and cannabidiol of Cannabis sativa Linn.
Figure 4 Obtained anxiolytic activity in mice performed by climbing out test (A), elevated plus maze-open arm (B), elevated plus maze- close
arm (C), forced induced swimming test (D) at 2 hr and 24 hr. NKB produced dose depending activity according to 100, 200 and 400 mg/kg/day.
The result of the diazepam (2 mg/kg/day) was used as standard to determine the anxiolytic activity of NKB (p < 0.05). The plant presence in the
NKB formulation named Canscora decussata (Roxb.) Schult., Canscora decussata (Roxb.) Schult. And Cannabis sativa Linn. may be the cause of this
activity in mice.
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A significant increase in time spent in the open arms of
maze and decrease in time spent in close arm of maze
(Figure 4) were observed in the low dose of NKB (100
and 200 mg/kg). The diazepam (3 mg/kg, i.p.) positive
control group, spent longer time in the open arms of the
maze (Figure 4).
Forced induced swimming test
There are significant differences in the swimming time
to exhaustion between the control group and each treat-
ment group. The swimming time to exhaustion of the
control, Diazepam and NKB groups were increased at all
doses (100, 200, 400 mg/kg) after 2 h and decreased after
24 h (Figure 4). Thus, the swimming times to exhaustion
of the NKB groups were significantly longer than that of
the control group (P < 0.05).
Hypnotic activity (CNS effects)
Pentobarbital sleeping time test
In the pentobarbital induced sleeping time test, the ex-
tract at a low dose 100 mg/kg and also diazepam (3 mg/
kg) significantly increased sleeping time (duration) in
treated group than the control group (Figure 5A).
Metabolic activity
Hypoxia test
NKB treated male mice decreased the survival time in the
hypoxia test at the dose 100 mg/kg. However, NKB didnot show any distinction from those of the control group
at the dose of 200 mg/kg and 400 mg/kg (Figure 5B).
Neuropharmacological activity
Rotarod test
NKB and diazepam lowered motion harmony and func-
tion within the rotarod program at 58 and 360 minute
after injections (Figure 5C).
Toxicological activity
Gastrointestinal motility test
In the gastrointestinal motility test, the NKB and stand-
ard antimotility drug loperamide significantly slowed
down the gastrointestinal transit of milk in comparison
to control (P < 0.01) (Figure 5D).
Gastric emptying time
Increased gastric emptying time was observed in mice
after 4 hour at the dose of 100 mg/kg (NKB) (Figure 5E).
This effect was almost same after 2 hour at most doses
of NKB (100, 200, 400 mg/kg).
Discussion
Screening and optimization of NKB effects
NKB is indicated as anticonvulsive, sedative, hypnosis, anti-
depressive, Analgesic, Anti-inflammatory, anti-nociceptive,
anxiolytic, antidiarrhoeal effects and to be useful for treat-
ing nervous breakdown, nervous tension, depression, and
insomnia. In this paper, we observed these mentioned
Figure 5 Hypnotic activity of NKB was performed using pentobarbital induced sleeping time test (A). The dose of NKB was used as 100 mg/kg/
day. NKB showed significant effect similar to diazepam. Metabolic study was conducted by observing survival time in seconds in the hypoxic
condition (B). Mice were treated low (100 mg/kg/day), medium (200 mg/kg/day) and high doses (400 mg/kg) (P < 0.05). Neuropharmacological
activity was studied for NKB using rotarod (C). Toxicity of the NKB was screened through gastrointestinal motility (D) and gastric emptying rate
(E). Active metabolites of Jatamansone of Nardostachys jatamansi DC; 3,4,5-trimethyl benzoic acid (structure shown, A) ester of reserpic acid, an
indole derivative of 18-hydroxy yohimbine type of Rauvolfia serpentina (L.), mangiferin, xanthones of Canscora decussata (Roxb.) Schult, crude fine
powder and alcoholic extraction of Canscora decussata (Roxb.) Schult., cannabidiol, and cannabinol of Cannabis sativa Linn., isolated constituted of
the rhizomes, asarone and β-asarone of Acorus calamus Linn. may be the principle cause to show the hypnotic activity. However, the use of the
plant Acorus calamus Linn. is not recommended in the NKB formulation due to its immunosuppressive activity, diarrhea and dysentery.
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fore, to study the inclusive effect of this herbal remedies,
the below targets were observed such as duration of sleep-
ing, onset of convulsion time, painful muscular contrac-
tion, duration of time in licking, locomotion parameters,
number of ambulation, number of fecal boluses excretion,
number of head dips, loss of initiative, curiosity, spontan-
eous coordination, swimming capacity, percent gastric
emptying and motility in mice.NKB relieves from the pain significantly
The acetic acid induced writhing is inversely proportion-
ate to doses of NKB as non-narcotic analgesic property.
At dose of 100 mg/kg, NKB treated male mice showed a
lower effect in writhing response from 1st minute to 5thminute in comparison to control group. The decrease of
writhing response was statistically highly significant (p <
0.01) at the 3rd minute. NKB treated mice showed
higher effect in writhing response at the dose of 200 mg/
kg and 400 mg/kg respectively in comparison to control
group. When administered (oral) to mice, the different
doses of NKB (100, 200 and 400 mg/kg) motivated the
writhing response induced by acetic acid administered
intraperitoneally to mice (Figure 1), in a dose-dependent
manner. The inhibition percentages of writhing obtained
with NKB were 14.70%, 69.41% and 74.11% respectively
at the dose (100, 200 and 400 mg/kg). The NKB showed
the most significant inhibitory effect (74.11% at the dose
of 400 mg/kg). The standard analgesic diclofenac sodium
(100 mg/kg) reduced the abdominal constriction to
47.05%. Usually, NKB is used for headache. The dose of
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cine practitioner in South Asia.
NKB formulation contains ample quantity of
phytoconstituents that responsible for analgesic activity
The writhing inhibition increased as the dose of NKB
was increased (Figure 1) in the analgesic activity per-
formed using acetic acid-induced writhing inhibition test
in mice. Herbal plants contain alkaloids, flavonoids, ste-
roids, and tannins according to qualitative phytochem-
ical screening [23]. Flavonoids, tannins, and alkaloids
may play a role in analgesic activity primarily by target-
ing prostaglandins [24,25]. Besides this, herbal plants
show analgesic effect due to steroids activity [25]. The
results justify the traditional use of NKB as an analgesic
in South Asia [26]. Percent protection of pain perception
of NKB was found as 47.83% (decreased), 121.90% (in-
creased), 40.800% (increased) at the dose of 100, 200,
400 mg/kg, respectively.
Centrally acting narcotic analgesics can inhibit both
phases of pain in formalin induced paw licking effect
model while peripherally acting drugs such as diclophe-
nac sodium can inhibit the late phase (inflammation)
[27]. NKB (100 mg/kg) showed higher analgesic activity
in the mice at the dose of 400 mg/kg. In the contrary,
NKB showed mild effect on inflammation at the dose of
100 mg/kg (P < 0.05).
Anti-inflammatory activity observed in NKB
Acetic acid acts indirectly by inducing the release of en-
dogenous mediators which stimulate the nociceptive
neurons sensitive to non-steroidal anti-inflammatory
drugs (NSAIDs) and opioids [28]. Acetic acid is respon-
sible for inflammatory pain by inducing capillary perme-
ability [29], formalin for neurogenic and inflammatory
pain [30], while hot plate-induced pain points out nar-
cotic involvement [31]. NKB (100, 200 and 400 mg/kg)
administered orally on inflamed and non-inflamed paws,
significantly reduced the increase in formalin induced
paw edema (Figure 1C, D). The NKB showed significant
anti-inflammatory activity at 100 mg/kg studied, as com-
pared with control group. The subcutaneous application
of the NKB on the non-oedematous paw reduced the in-
flammation of the oedematous paw. The reason may be
for the transdermal absorption to produce a systemic ef-
fect. Formalin induced edema is usually correlated with
the early exudates-stage of inflammation as inflamma-
tory pathology [32]. The increased gradually inflamma-
tion may be due to the liberation of prostaglandins and
kinins, which accompany leukocyte migration [33]. No
written rules is found to prescribe specific amount of
dose for anti-inflammatory use of NKB. Plants used in
the NKB responsible for anti-inflammatory effect may be
prescribed as 50 to 200 mg/kg/day (Table 3).The inflammatory cytokines may bind with NKB’s active
principles that showed antagonistic activity
Distinctive nociceptive response is defined in early and
late phases in the formalin test. The anti-nociceptive ac-
tion in the formalin test of NKB paralleled with inhibi-
tory effect of acetic acid-induced writhing. This model
produces a distinct non-biphasic nociception. Drugs ef-
fect on the central nervous system can inhibit both
phases equally while peripherally acting drugs inhibit the
late phase [34,35]. The reason of early phase (neuro-
genic) may be for the stimulation of nociceptors in the
paw which states centrally mediated pain while the late
phase (inflammation) is due to release of serotonin, his-
tamine, bradykinin and prostaglandins [36]. The NKB
(100 mg/kg) significantly reduced compared to other
samples in late phase. Formalin induced early phase and
late phase inflammations is due to release of histamine
and bradykinin and prostaglandin. NKB demonstrated
better activity in late phase than early phase. These
phases can be used to assess the potency of analgesic
and the mechanisms of pain and analgesia. However, an-
algesic activities is different in the early (neurogenic) and
late (inflammatory) phase. Acetic acid induced writhing
test was used for detecting both central and peripheral
analgesia. In acetic acid induced mice, acetic acid re-
leases prostaglandins and sympathomimetic system me-
diators (PGE2 and PGF2α) with peritoneal fluid [37].
Abdominal constrictions shown in Figure 5D, E, in
acetic acid might be related to sensitization of nocicep-
tive receptors to prostaglandins. It is, therefore possible
that the NKB exerted their analgesic effect by inhibiting
the synthesis of prostaglandins. NKB exhibited signifi-
cant anti- nociceptive (pain) activity as compared to
control group (Figure 1C, D). NKB may show its effect
through central opioid receptors or promoted release of
endogenous opiopeptides.NKB exerted peripheral effects due to presence of
flavonoids etc.
In the present study, the NKB significantly exhibited
anti-inflammatory effects. As inflammation is a periph-
eral process, therefore, it is suggested that the NKB also
exerted peripheral effects. In fact, the licking activity in
the formalin test was strongly diminished in the second
phase, whereas this reduction was more discreet in the
first phase. Central and peripheral mechanisms may be
the reason of this effect for the presence of phytochem-
ical such as anthocyanins, proanthocyanidins, and fla-
vonoids [30], which have potential antinociceptive and
anti-inflammatory effects. Also, bioactive flavonoids
such as rutin, quercetin, luteolin, hesperidin, as well as
biflavonoids produce significant antinociceptive and/or
anti-inflammatory activities [24,38]. Advance studies
Table 3 Effects of each plant constituent in NKB
Plant Chemical components Effects of plant extract Effect of plant parts Effect of active principles
Nardostachys
jatamansi DC
Terpenoids [70], alkaloids [71], neolignans,
3 lignans [72], coumarins [73], other
compounds [74,75].
50% rhizomes ethanol extract – hepatoprotective [76],
liver damage protection in vivo [77], hypolipidaemic
effects in vivo [78], antiarrhythmic activity [79].
Hexane extract hair growth activity
Rhizome preparation of
medicinal oils, [80] to
promote growth of hair
[79], imparts blackness [79].
Essential oil (from the roots) fungi toxic
activity [80]. Antimicrobial [81]. Antifungal [82].
Hypotensive [83] Antiarrhythmic [84]
anticonvulsant activity [85]. BR606 bone
sorption inhibitor for the treatment of
osteoporosis and hypercalcemia [86]
jatamansone (valeranone) hypotensive and
tranquilizing agent, [87] antiarrhythmic and
anticonvulsant agent [84] sedative activity






resins, saponins sterols, tannins terpenes
different alkaloids (monoterpenoid indole




serpentinine, yohimbine. ascorbic acids,
riboflavin, thiamine, niacin [88]






3,4,5-trimethyl benzoic acid ester of reserpic
acid, an indole derivative of 18-hydroxy
yohimbine type: natural tranquillizing effect.
[89,90] Serpentine, type II topoisomerase
inhibitor, antipsychotic properties [91,92]
Alkaloid, ajmalicine: function of smooth
muscle, prevent strokes and helps, in
lowering blood pressure [93] Rescinnamine
ACE inhibitor [94] Alkaloid Yohimbine
selective alpha-adrenergic antagonist





Alkaloids, terpenoids, phenolics phenolic
compounds, xanthones, triterpenoids
pentaoxygenated, hexaoxygenated, dimeric
xanthones, bitter substances, oleoresin,
mangiferin 1,5-dihydroxy-3-methoxy (X),
1-hydroxy-3,5-dimethoxy (VII), 1,3,5-trihydroxy-






(XV), 1,3,6,7,8-pentahydroxy (XVI) xanthones
Petroleum extract CNS depression decreased motor
activity, sedation, diminished response to external
stimuli mangiferin (50 mg/kg) potentiate subnarcotic
effect. mangiferin inhibition of reserpine-induced
ptosis, sedation, depression of locomotor activity
[96] ethanolic extract (400 mg/kg) reduce the
neuromuscular coordination indicative of the
muscle relaxant activity [97] crude fine powder
and alcoholic extraction hypnotic activity [98]
chloroform-soluble fraction of ethanolic extract
antimicrobial [99] aqueous preparation activation
of cell adhesion molecules [100] Extract
antiinflammatory activity [101] spermicidal
activity [102]
Same as effect of extract
and active principles
Total xanthones CNS depression
polyoxygenated xanthones antimicrobial
mangiferin; Acute toxicity, CNS stimulation,
mangiferin induced tremors, pilo erection,
compulsive gnawing, increased motor activity
mangiferin and the total xanthones (50 mg/kg)
induce pentobarbitol sleeping time, transient
positive inotropic effect no analgesic activity no
diuretic effect (100 mg/kg) no significant effects
dog’s carotid blood pressure, respiration,
intestinal movements [103] magostin-3,6-di-O-
glucoside and mangiferin, a C-glucoside (roots
extract) protection against liver injury in vivo
[104] mangiferin anti-necrosis in vivo, sedation
and ptosis in vivo, potentiation of amphetamine
toxicity in vivo, potentiation of dihydroxypheny
lalanine (DOPA) effect in vivo, potentiation of
5-hydroxytryptophan effects in vivo,
potentiation of subanalgesic dose of morphine
in vivo (Bhattacharya et al.)
Phyllanthus
emblica L.
Fixed oils, phosphatides, essential oils,
tannins, minerals, vitamins, amino acids,
fatty acids, glycosides Fatty acids: linolenic,
linoleic, oleic, stearic, palmitic, myristic acids.
major tannins: D-glucose, D-fructose,
D-myo-inositol, D-galacturonic acid,
D-arabinosyI, D-rhamnosyl, D-xylosyI,
Aqueous infusion and decoction: strong antibacterial
activity [105] leaf extract antimalarial potency [106].
The chloroform soluble fraction of methanolic extract
antimicrobial activity in gram positive and gram
negative pathogenic bacteria strong cytotoxicity [107]
hydro-methanolic extract normalize the impaired




of leaves fever fresh fruit
refrigerant. seeds cooling
remedy in bilious affections
nausea, fevers [116]
1,2,4,6-tetra-O-galloyl-β-D-glucose: anti-viral
activity against anti-herpes simplex virus [117]
ascorbic acid, tannins and polyphenolic
constituents: antioxidant and free radical
scavenging activity [118] tannins, corigalin and
its analogue anti-atherosclerosis [119]



















Table 3 Effects of each plant constituent in NKB (Continued)
D-glucosyI, D-mannosyl, D-galactosyI residues-
sugars, Emblicanin A Emblicanin B,
Pedunculagin, punigluconin Other
compounds: gallic acids, amlaic acid,
arginine, aspartic acid, astragallin,
β-carotene, β-sitosterol, chebulagic acid,
chebulic acid, chebulaginic acid, chebulinic
acid, corilagic acid, corilagin, cysteine, ellagic
acid, emblicol, ibberellins, glutamic acid,
glycine, histidine, isoleucine, kaempferol,
leucodelphinidin, methionine, phenylalanine,
phyllantidine, phyllemblic acid, quercetin,
riboflavin, rutin, thiamin, threonine,
tryptophan, tyrosine, valine, zeatin
spasmolytic activities [109] water fraction of fruits
butanol extract potential anti-inflammatory [110].
Extract affected the mode of absorption as well
reduces serum, aortic and hepatic Cholesterol
[111] aqueous extract natural killer cell activity
antibody-dependent cellular cytotoxicity [112]
aqueous extract anticancer effect [113]. Extract
chondroprotective Effects [114]
phenolic compounds The antiproliferative
activity of tumor cell lines, MK-1, HeLa, and
B16F10 cells phytosterol compounds cytotoxic




Saponins, tannins, alkaloids, glycosides,
alkaloids, tannins, carbohydrates, proteins,





hyoscamine scopolamine [123] tropane
alkaloids, 3-phenylacetoxy-6, 7-epoxynortropane,







hydroxytropane, aponor scopolamine, 3â,
6â-ditigloyloxytropane, 7-hydroxyhyoscyamine



















Extract asthma treatment The ethanol extracts (leaf
and seed) acaricidal, repellent oviposition deterrent
[125] methanol extracts antibacterial [126]. Extract
anticancer activity produce vomiting, hypertension,
loss of consciousness that interacts with anti-
cholinergic drugs [127] ethanolic extracts anti-
inflammatory activity [128]. Ethanolic extracts of
leaves larvicidal and mosquito repellent activities
[129]. Extract effective in countering the toxicity of
the cypermethrin pesticide toxicity [130]. Antifungal
activity [131]. Aqueous and organic solvent extracts
broad-spectrum vibriocidal agents [132] ethanol
extract of the leaves increased Serum creatinine levels,
affect on biochemical and haematological parameters
[133] extract treatment of organophosphate poisoning
[134]
Same as effect of extract
and active principles
Alkaloids (organic esters): anticholinergic
agents [135] alkaloids atropine and



































(CBD),α-Pinene, Myrcene, Linalool, Limonene,
Trans-β-ocimene, α-Terpinolene, Trans-
caryophyllene, α-Humulene, Caryophyllene-




methoxyphenol and canniprene, acylated
0-glucoside of apigenol, 0-glycosides
of vitexin, isovitexin, orientin (leaves);
a-bergamotene, b-caryophyllene, trans-b-and
a- farnesene isomers, a-humulene,
g-elemene, a-gurjunene, b-bisabolene,
b- caryophyllene-epoxide and a-bisabolol,
cannabinoids, tetrahydro-cannabinol,
cannabinol, n-alkanes ranging from C, to C,
2-methyl alkanes, 3-methyl alkanes, dirnethyl
alkanes, a-pinene, myrcene, limonene,
terpinolene, longifolene, humulene epoxides
I & 11, m-mentha-1,8 (9)-dien-5-01 (essential







b-sitosterol, carvone, dihydrocarvone and





carboxylic acid), its acetate, cannaoidiol,
cannabinol, tetrahydrocannabinol,
trans-cinnamic acid, n-nonacosane, eugenol,
guaiacol, cannabidivarin, tetrahydrocannabivarin,
cannabivarichromene, L(+)- isoleucine betaine,
zeatin and zeatin nucleoside, vitexin, isovitexin,










The bark tonic, inflammations,
haemorrhoids and hydrocele.







is smoked to allay hiccough
and bronchitis insomnia, sick
headaches, neuralgia, migrain,
mania, whooping cough,
asthma, dysuria relieving pain
in dysmenorrhoea and
menorrhagia
Cannabigerolic Acid: Antibiotic cannabigerol:
antibiotic, antifungal, anti-inflammatory,
analgesic, GABA uptake inhibitor, reduces
keratinocytes proliferation in psoriasis,
Effective against MRSA, cannabichromene:
antibiotic, antifungal, anti-inflammatory,





effects of THC, Decreases sebum/sebocytes
proliferation, effective against methicillin-
resistant staphylococcus aureus, pro-apoptotic
against breast cancer cell lines Cannabinol:
Sedative, Antibiotic, Anti-convulsant,
Anti-inflammatory, Decreases breast cancer
resistant protein, effective against MRSA,
Delta-9 tetrahydrocannabinol: Euphoriant,
Analgesic, Anti-inflammatory, Antioxidant,
Antiemetic, Antipruritic, Bronchodilator Delta 9
tetrahydrocannabivarin: Analgesic, Euphoriant,
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hydrocannabinol, 4-hydroxymethyl benzoate and
4-hydroxy-n-propyl benzoate, delta-9-
tetrahydrocannabinol, dihydrostilbenes-




β-Asarone (isoasarone), α-Asarone, elemicine,
cis-isoelemicine, cis and trans isoeugenol and
their methyl ethers, camphene, P-cymene,









Ethanolic and aqueous extract and methanolic
extract antibacterial [139,141] extract asthma [142].
The ethyl acetate fraction hypoglycemic, hypolipidemia
[143]. Extract inflammatory activity ethanolic extract
of the rhizome: Antiulcer cytoprotective activity [144]
ethanolic extract of rhizome immunosuppressive,
moderately hypotensive respiratory depressant




coconut oil extract of the
rhizomes 45% inhibition of
carrageenan-induced rat
paw edema and 61% inhib-
ition using the granuloma
pouch method [146]
β-asarone compound fraction (crude
methanolic extract of rhizomes): antifungal
activity [147] Phenolic compounds:
antioxidant activity [148] β-asarone and
essential oil of the rhizomes: diarrhea and
dysentery [149] The essential oil and alcoholic
extract of the rhizomes: Analgesic activity
[150] The essential oil: anti-inflammatory
activity; The isolated constituted of the
rhizomes, asarone and β-asarone:
anticonvulsant activity [151,152] Acorus
calamus oil induce malignant tumours, due to
β-asarone in vitro and in vivo [152]
Chemical components presence in NKB may have potential interaction to produce the adverse reaction, side effects and harmful chemistry. The reported active principles may produce the probable mechanism of



















Zaman et al. BMC Complementary and Alternative Medicine  (2015) 15:121 Page 16 of 22may find out the mechanisms of action of NKB and
their active compounds.
NKB treated male mice showed lower effect in inflam-
mation in the xylene induced ear edema test at dose
400 mg/kg. The NKB administered orally showed a
minor inhibiting effect against ear oedema induced by
xylene at the dose of 100 mg/kg. The inhibition figures
were 36.36%, 51.92%, and 78.68% at the dose of 100, 200
and 400 mg/kg respectively while dexamethasone
(50 mg/kg) exhibited an inhibition percentage of ear
oedema of 30% as shown in Figure 1B.
NKB formulation contains significant amount of CNS
stimulant and depressant phytochemicals
The pentobarbital induced sleeping time in mice is dir-
ectly proportionate to the CNS depressant activity. NKB
treated female mice showed mild effect in the onset time
and higher effect in the duration of sleeping time of the
pentobarbital induced sleeping time test at the dose of
100 mg/kg according to control group. The onset of
sleeping time is directly related to the CNS stimulant ac-
tivity. It can be inferred that NKB has CNS stimulant ef-
fect that is supported to the use of NKB as CNS drug on
the cerebral cortex. NKB formulation contains a lot of
CNS active compounds to produce this effect (Table 3).
NKB is not familiar to prescribe it as CNS stimulant
medicine and hence no specific dose is found from the
traditional knowledge.
The result of the present study indicates that the NKB
produced a significant alteration in potentiation of
pentobarbitone-induced sleeping time in a dose depen-
dent mode. This may be due to enhancement of barbital
hypnosis as a good index of CNS depressant activity
[39]. NKB might have central nervous system depressant
action thru its GABAergic and glycinergic transmission
since pentobarbital is a selective GABAA receptor antag-
onist [40]. The CNS depressant activity of NKB observed
in our study could be due to the presence of bufadieno-
lide and other water soluble constituents in this herbal
medicine. One of the researches on phytochemical evalu-
ation of a medicinal plant showed the presence of bryo-
phyllum A, B and C, a potent cytotoxic bufadienolide
orthoacetate [41]. Bufadienolide was not isolated and its
side effects in this study.
NKB affected the psychological behaviors
The psychopharmacological study was carried out to
find the locomotor effects of the drugs in the behavioral
pattern characterized by spontaneous ambulatory activ-
ity, Centre ambulatory activity, Standing activity and
emotional defecation of the animals (Figure 2). NKB
treated female mice showed higher effect in total ambu-
latory activity at doses of 100 mg/kg (p <0.05) at 120 min
and in 400 mg/kg. NKB treated group showed lowereffect in ambulatory activity at the dose of 200 mg/kg at
120 min. NKB treated female mice exhibited higher effect
in central Ambulation at dose 100 mg/kg at 240 min
compared to the control group. NKB treated group
exerted lower effect in central ambulation at doses
200 mg/kg and 400 mg/kg than 100 mg/kg (Figure 2).
NKB treated female mice exerted higher effect in stand-
ing up behavior at doses of 100 mg/kg and 400 mg/kg at
120 min (p < 0.05) in comparison to that of the control
group. NKB treated group showed lower effect in stand-
ing up behavior at dose of 200 mg/kg 60 min in compari-
son to that of the control group. NKB increased
emotional defecation at the dose of 100 mg/kg in com-
pared to control group and decreased at the dose of
200 mg/kg and 400 mg/kg at 60 min and 120 min and at
30 min and 60 min respectively.Anxiolytic activity also was observed from the
psychological test method due to presence of alkaloids,
flavonoids and saponins
The hole board apparatus was used in the measurement
of head dipping behavioral responses of mice to an un-
familiar environment. NKB treated female mice showed
an overall decrease in ambulatory activity in the hole
board test at the dose of 200 and 400 mg/kg at 120 min
compared to the control group (Figure 3A). NKB treated
group showed an overall decrease in head dipping activ-
ity in the hole board test at the dose of 200 mg/kg
(Figure 3B). NKB treated group showed higher effect in
emotional defecation at the doses 200 mg/kg, and
400 mg/kg at 30 min (Figure 3C). The drug showed
lower effect in the emotional defecation at the 1st hour
at the doses of 100 mg/kg. Decrease in the number of
head dips was measured and groups that received NKB
(100, 200 and 400 mg/kg) and diazepam 2 mg/kg had
shown significant decrease in head dip counts. The anxio-
lytic effect of alkaloids [42], flavonoids [43] and saponins
[44] has been previously reported and, therefore, it may be
suggested for anxiolytic effects for these constitutes. Most
of the anxiolytic agents exert their action by opening of
activated GABAchloride channel. It is also reported that
many flavonoids were found to be ligands for the GABA-
A receptors in the central nervous system.NKB showed anxiolytic activity by modulating the
GABAergic activity
NKB only for a medium dose induced a hypnotic conse-
quence. These effects associated with NKB were similar
to diazepam activity. In truth NKB showed antianxiety,
sedative and lean muscle relaxation effects as being a
benzodiazepine. These effects might be for the inhibitory
systems like GABAergic. Flavonoids isolated from plants
show to hold the affinity for GABAA/BDZ receptors as
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action dose dependently mainly because it increased the
percentage of time spent on view arms. The reason associ-
ated with hypnotic activity might be due to binding with
the phytochemicals of used plant in NKB to benzodiaze-
pines receptors (BZ1, BZ2 and BZ3) to exhibit anxiolytic,
hypnotic, lean muscle relaxation and anticonvulsant [47].
Anti-depressant activity of NKB was found in the
locomotion and plus maze test
Locomotor activity test is normally used for evaluation
of central nervous system depressant and stimulant
agents. It has been reported that various antidepressants
like tricyclic antidepressants and monoamine oxidase in-
hibitors decrease locomotor activity of the mice [48,49].
In our research NKB and standard antidepressants also
reduced the general locomotor behavior of the mice, at
dose range that showed profound antidepressant activity
in other behavioral tests. Thus, supporting that anti-
depressant effect of either NKB or standard antidepres-
sants was not due to stimulation of the central nervous
system. Diazepam is known for its action to inhibit amino-
butyric acid type-A gamma aminobutyric acid (GABA)-ac-
tivated channel [50]. It causes convulsions by inhibiting
chloride ion channels associated with GABA-A receptors.
NKB showed CNS depressant activity in hole cross study
In hole cross experiment, NKB treated mice showed
lower effect at 100 and 200 mg/kg and effect was higher
according to increased dose level to the 400 mg/kg &
400 mg/kg (Figure 3D). Gamma-amino-butyric acid
(GABA) is the major inhibitory neurotransmitter in the
central nervous system. CNS depressant drugs show
their action through GABAA receptor [51]. The sedative
effect of the NKB at the doses (100, 200 and 400 mg/kg,
Figure 3) may be due to hyperpolarization of the CNS
via interaction with GABAA or benzodiazepine receptor.
The decrease in locomotion activity by diazepam treated
mice compare with the control may be due to the dose
(400 mg/kg) used in the test that can produce sedation
in mice [52].
NKB’s higher and lower doses increased the
anti-convulsion effects in plus maze and climbing study
Almost all doses of NKB decreased locomotion activity
and behavioral parameters in the elevated plus maze test
in a dose-dependent manner. It is recorded that NKB
have been used in reducing fear, curing trance and some
other disorders in the central nervous system for in-
stance, convulsion caused through fever and despression
symptoms [53]. Herbs may lessen the motor activity and
prolonged your sleeping time elicited by hexobarbital
plus ameliorated ethanol-induced disability of learning
along with memory [53,54]. In Climbing out experimentthe decreased number of animals climbed out of the cage
and increased number to come out of the cage with the
time was directly proportionate to the doses (Figure 4A).
NKB treated mice exerted lower effect at the dose of
400 mg/kg to come out of the cage. On low doses (100 mg/
kg), NKB increased any time spent in the open-sided arms
and this indicated an antianxiety effect of this herbal medi-
cine (Figure 4B). However, this effect suggests the presence
of sedative effects.
Anxiolytic activity of NKB was found in plus maze and
psychopharmacological effect in hole board study
Anxiolytic activity was evaluated using elevated plus
maze paradigm and psychopharmacological activity by
using hole board test. The Elevated Plus-Maze (EPM)
test is used for screening anxiolytics [52]. The fear due
to height induces anxiety in mice when placed on the
apparatus. Mice will normally prefer to spend much of
their allotted time in the closed arms. This preference
appears to reflect an aversion towards open arms that is
generated by the fears of the open spaces. In the present
study, the total time in open arm was found to increase
by the NKB (100 mg/kg). This indicates the anxiolytic
activity of NKB. NKB 100 mg/kg shows significant in-
crease in total arm entries which indicates the depres-
sion of locomotion by low dose of NKB. Decrease in
movement in close arm was found at the dose 200 and
400 mg/kg. Its validity in our study was supported by
the observation that diazepam, a classic anxiolytic, sig-
nificantly increased the time spent in the open arms.
The behavior observed using the EPM (elevated plus
maze) in the present study confirmed the anxiolytic ac-
tivity of diazepam. Using this test the NKB increased the
percentage of time spent in the open arms. The NKB,
similarly to diazepam, increased the time spent in the
open arm. These results are suggestive that NKB has an
anxiolytic-like effect in the plus-maze test.
Potential significant signs are produced by NKB in
swimming test
FST (forced swimming test) is usually used for evalu-
ation of antidepressant agents. When a normal animal is
forced to swim in an unsuitable area from which there is
no escape, it is interested to immobility posture, reflect-
ing a state of ‘behavioural despair’ [48]. Clinically used
antidepressants have been shown to decrease the immo-
bility time in rodents and non-rodents. NKB (100 mg/
kg) treated group showed an increase in the immobile
phase of the forced induced swimming test after 2 hour
(Figure 4D). This effect was similar to tricyclic, monoamine
oxidase inhibitors and other atypical antidepressants
[48,49]. The observed U-shape (Figure 4D at 24 h) (bi-
phasic effect) dose–response relationship in FST may
be due to mixture of phytochemical compounds of
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of immobility in the swim test may be due to activat-
ing catecholaminergic mechanism in the brain [55,56].
The attenuation of immobility in FST by NKB indi-
cates that this effect may have occurred due to in-
crease level of catecholamine, possibly noradrenaline in
the brain.NKB produced higher sedative effects than diazepam
NKB showed increased sedative effect similar to that ob-
served with 3 mg/kg diazepam in the Pentobarbital in-
duced sleeping test (Figure 5A), after oral administration
of 100, 200, and 400 mg/kg dosages. Diazepam is an ap-
proved anxiolytic benzodiazepine (BDS) which produces
both anxiolytic-and sedative effects. In this respect, we
found a dose-dependent reduction in NKB in the num-
ber of head dips in the hole-board test similar and/or
greater than diazepam.
Usually locomotor activity results from brain activa-
tion as an excitation of central neurons involving differ-
ent neurochemical mechanism and an increase in
cerebral metabolism. The sedative activity of NKB may
be mediated by GABAergic pathway, since GABAergic
transmission can produce profound sedation in mice
[57]. GABA inhibits the process in the opening of chlor-
ide channels to allow hyperpolarizing the membrane,
leading to CNS depression for sedative and hypnosis ac-
tivity. The excitatory and inhibitory neurotransmitters
are Glutamate and GABA in the mammalian brain re-
spectively [58]. Thus, these receptors of these two neu-
rotransmitters are targeted for psychotropic drugs.NKB supports its use as folk medicine due to significant
duration of efficacy
In the test of pentobarbital-induced sleep in mice, NKB
not only prolonged the sleeping time but also decreased
the latency of falling asleep. The NKB produced hypno-
sis at high dose of 200 and 400 mg/kg. This results
showed that NKB contains Phytochemical of coumarin,
chalcones, flavanones, flavones, flavonols, quercetin, and
kaempferol derivatives to work as the pentobarbital on
the CNS involves the activation of the inhibition
GABAergic system [59-63] (Table 3). In conclusion, ad-
ministration of NKB induces similar sedative effects,
supporting its use in folk medicine. It seems that that
the LD50 value for this herbal drug was beyond
1000 mg/kg for oral administration. So there may be a
remote risk of acute toxicity and good tolerance of the
plants used in this traditional medicine of NKB which
has obvious sedative and hypnotic activity and provides
a pharmacological basis for its therapeutic efficacy on
insomnia.Survival time is lower due to use of NKB
The hypoxia induced convulsion onset time is inversely
proportionate to the brain oxygen demand. NKB treated
male mice showed lower survival time in hypoxia test at
the doses of 100 mg/Kg and no effect found in 200 mg/
kg and 400 mg/kg too (Figure 5B).
NKB affects the motor coordination in neurons
Muscle intoxicant and motor disproportion were found
in the obtained results of the rotarod test. The rotarod is
sensitive to drugs that affect motor coordination. The
experiment was carried out to find the pattern of behav-
ior, characterized by percentage of fall and number of
falling. NKB treated female mice showed increasing ef-
fect in the total fall of the rotarod test at the dose of
400 mg/kg. This increased effect was observed only in
the initial 1st hour at the dose of 400 mg/kg.
Anti-diarrheal and higher intestinal motility is found in
NKB
The common side effects such as mild diarrhoea, loss of
weight, depression and varied weight after 7 days were not
recorded. The mice treated with doses up to 400 mg/kg of
NKB exhibited significant anti-inflammatory and analgesic
activities. Therefore, we tried to investigate whether this
dose would provoke any genotoxic effect.
The milk meal model is used for finding the GIT mo-
tility in animal Changes in tannin content, polymerisa-
tion and models [64,65]. The significant GIT motility
was protein precipitation capacity with increasing the
dose of NKB (Figure 5D). The NKB is good constipating
as it increased the intestinal motility.
Gastric emptying test was carried out in order to as-
sess the effect of the NKB on the emptying of a solid
meal from the gastric cavity. NKB treated male mice
exerted increased effect 30% (Lapse time) in gastric
emptying at the dose of 100 mg/kg (Figure 5E). The
NKB also inhibited normal gastric emptying; this effect
may be linked to the reduction in gastrointestinal pro-
pulsion observed in the mice. Decrease in intestinal
transit time by morphine and atropine are linked to
delay in gastric emptying [66-69]. This suggests that the
plant may have morphine-like action in exerting its anti-
diarrheal activity.
Comparative overall effects of the NKB
A reciprocal result was found in NKB treated female
mice using pentobarbital induced sleeping in CNS activ-
ity test. Higher CNS activity was found at the dose of
200 mg/kg but other doses showed little effect. The
same dose (200 mg/kg/day) is used by the herbal medi-
cine practitioner for the treatment of sleeping disorder.
NKB treated male mice, showed lower metabolic effect in
the survival time of the hypoxia test at the dose 100 mg/
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of 200 and 400 mg/kg (p <0.01) in the Acetic Acid in-
duced abdominal writhing test. Reverse effect was ob-
served at the lower doses (100 mg/kg) and suggest an
adjustment of doses to get proper analgesic effect. Mild
analgesic and higher anti-inflammatory effect of NKB (P <
0.05) observed by formalin induced paw licking test and
higher anti-inflammatory effect of NKB were found in
xylene induced ear edema test. Neuropharmacological ef-
fects were determined using open field test of ambulation,
standing up behavior, emotional defecation and hole board
test, locomotor test and hole cross test those showed posi-
tive effect dose dependently. Observed psychopharmaco-
logical effects using climbing out test, elevated plus maze,
showed better effect at the dose of 100 mg.kg of NKB. Ob-
served results from toxicology study by screening the rate
of gastrointestinal motility and gastric emptying rate
showed opposite effect based on the use of dose. In gastric
emptying, higher rate at higher doses but NKB with lower
dose of 100 mg/kg (p < 0.040) showed an increase gastro
intestinal motility. The plant Acorus calamus Linn. may be
responsible for this effects (Table 3). The results of the
present work clearly demonstrate the significant anti-
inflammatory and peripheral analgesic activities of the dif-
ferent doses of NKB. The same medicine exhibited gastric
emptying and gastrointestinal motility effects. On the
other hand, NKB influence some side effects. These results
indicate that NKB might have toxic dose properties that
can be exploited in food and pharmaceutical industries.
Conclusions
A comprehensive screening was performed to determine
the mechanism of action of NKB formulation. Most of
the herbs in the NKB showed the hypnotic, metabolic, an-
algesic, anti-inflammatory, psychopharamcological, anxio-
lytic, neuropharamcological and toxicological activity.
The plant showed the respective activity was tried to
correlate with the earlier published studies. It has been
found that Canscora decussata (Roxb.) Schult. has no
effect as analgesic activity. Anti-inflammatory activity
found from the Datura stramonium Linn. but its ac-
tive compounds alkaloids atropine and scopolamine
may cause diarrhea, vomiting and cytotoxicity (Table 3).
Acorus calamus Linn. may be responsible for hypnotic
activity but it showed diarrhea and immunesuppressive
activity (Table 3). Apart from this the metabolic activ-
ity, gut motility and gastric emptying activity may be
due to these three herbs. These findings might be
fruitful to develop the NKB with rational scientific and
evidence based design. It is proposed that the herbs
used in the NKB’s composition and their active princi-
ples with similar kind of properties need to be revised
for optimum activity. In case of dose determination,
100 mg/kg/day is recommended as effective concentrationof NKB to optimize the desired efficacy and safety. This
strategy might be helpful for optimum pharmacological ef-
fects and safety for NKB and other herbal medicines, too.
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